Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director · Chairman and CEO | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 54.005 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 54.005 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 53.2963 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 53.2963 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 65.3344 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 7.9884 · Balance 65.3344 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 70.4281 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 9.5728 · Balance 70.4281 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 65.0639 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 11.6845 · Balance 65.0639 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 67.0809 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 13.2391 · Balance 67.0809 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 50.6104 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 19.5865 · Balance 50.6104 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 8, 2026 20:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 19.5865 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385310 · ownership.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50.6104 Underlying: Common Stock · 19.5865 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 13.2391 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385310 · ownership.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67.0809 Underlying: Common Stock · 13.2391 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 11.6845 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385310 · ownership.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65.0639 Underlying: Common Stock · 11.6845 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 9.5728 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385310 · ownership.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70.4281 Underlying: Common Stock · 9.5728 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7.9884 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385310 · ownership.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65.3344 Underlying: Common Stock · 7.9884 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.6726 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385310 · ownership.xml · derivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53.2963 Underlying: Common Stock · 4.6726 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.6726 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385310 · ownership.xml · derivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54.005 Underlying: Common Stock · 4.6726 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 16.8053 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · derivative · entry 9 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31.0239 Underlying: Common Stock · 16.8053 shares Expires not disclosed F8 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 11.3593 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · derivative · entry 8 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53.8418 Underlying: Common Stock · 11.3593 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 10.0254 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53.3794 Underlying: Common Stock · 10.0254 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8.2136 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60.8553 Underlying: Common Stock · 8.2136 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6.854 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57.346 Underlying: Common Stock · 6.854 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.0092 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48.6237 Underlying: Common Stock · 4.0092 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.0092 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49.3324 Underlying: Common Stock · 4.0092 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 11,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 Disclosed balance after: 45,374 F1 · ownership.nature: These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:29 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 11,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-259976 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,418,045 Read SEC document |
| May 08, 2026 Filed May 11, 2026 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 27,881 | $108.69 | $3,030,399.83 |
DisclosureSEC source: 0001193125-26-217345 · ownership.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,430,019 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $107.41 to $109.73. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 07, 2026 Filed May 11, 2026 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 18,600 | $107.64 | $2,002,012.86 |
DisclosureSEC source: 0001193125-26-217345 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,457,900 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $107.10 to $108.00. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 14.2186 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-131961 · ownership.xml · derivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.2186 Underlying: Common Stock · 14.2186 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 9.6109 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-131961 · ownership.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42.4825 Underlying: Common Stock · 9.6109 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8.4824 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-131961 · ownership.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43.354 Underlying: Common Stock · 8.4824 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6.9494 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-131961 · ownership.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52.6417 Underlying: Common Stock · 6.9494 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5.799 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-131961 · ownership.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50.492 Underlying: Common Stock · 5.799 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.3921 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-131961 · ownership.xml · derivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44.6145 Underlying: Common Stock · 3.3921 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:34 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.3921 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-131961 · ownership.xml · derivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45.3232 Underlying: Common Stock · 3.3921 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 01:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 55,930 | $107.81 | $6,030,020.24 |
DisclosureSEC source: 0001193125-26-086259 · ownership.xml · nonDerivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,476,500 F6 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.95 to $109.49. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 01:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086259 · ownership.xml · nonDerivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,532,430 Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086259 · ownership.xml · derivative · entry 8 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32.87 Underlying: Common Stock · 13 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · shares: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 496 | $113.69 | $56,390.24 |
DisclosureSEC source: 0001193125-26-086259 · ownership.xml · nonDerivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,537,430 F5 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086259 · ownership.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,537,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F4 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 5,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086259 · ownership.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,537,913 F3 · shares: These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 150,000 | $106.76 | $16,013,355.00 |
DisclosureSEC source: 0001193125-26-086259 · ownership.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,532,304 F1 · price: Sold pursuant to a 10b5-1(c) plan adopted 03-10-2025. F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $103.05 to $113.50. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · derivative · entry 19 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41.2224 Underlying: Common Stock · 39 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F12 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F12 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F12 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · derivative · entry 18 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41.9311 Underlying: Common Stock · 39 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F11 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F11 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F11 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,182 | $0.00 Strike: $54.65 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · derivative · entry 17 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,191 Underlying: Common Stock · 6,182 shares Expires 2030-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,075 | $0.00 Strike: $47.19 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · derivative · entry 16 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,194 Underlying: Common Stock · 7,075 shares Expires 2029-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,733 | $0.00 Strike: $48.60 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · derivative · entry 15 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,733 shares Expires 2028-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,155 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · derivative · entry 14 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,155 shares Expires 2027-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 663 | $84.00 | $55,692.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 12 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,682,304 F6 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 11 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,682,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 663 | $84.00 | $55,692.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 10 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,682,928 F5 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 9 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,683,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 12,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 8 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 Disclosed balance after: 33,400 F4 · ownership.nature: These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 12,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,683,552 Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 6,182 | $54.65 | $337,846.30 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,695,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,075 | $47.19 | $333,869.25 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,689,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,733 | $48.60 | $375,823.80 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,682,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5,155 | $37.29 | $192,229.95 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,674,662 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · derivative · entry 13 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · balance_after: Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 23:14 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 652 | $83.36 | $54,350.72 |
DisclosureSEC source: 0001193125-25-319553 · ownership.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,669,507 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.